NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 35 filers reported holding NOVELION THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $315,000 | +46.5% | 256,400 | 0.0% | 0.01% | +62.5% |
Q4 2018 | $215,000 | -71.7% | 256,400 | 0.0% | 0.01% | -60.0% |
Q3 2018 | $759,000 | -19.6% | 256,400 | 0.0% | 0.02% | 0.0% |
Q2 2018 | $944,000 | +5.2% | 256,400 | 0.0% | 0.02% | +81.8% |
Q1 2018 | $897,000 | +12.1% | 256,400 | 0.0% | 0.01% | -8.3% |
Q4 2017 | $800,000 | -55.6% | 256,400 | 0.0% | 0.01% | -61.3% |
Q3 2017 | $1,802,000 | -23.9% | 256,400 | 0.0% | 0.03% | -24.4% |
Q2 2017 | $2,367,000 | -14.1% | 256,400 | 0.0% | 0.04% | -32.8% |
Q1 2017 | $2,754,000 | +27.6% | 256,400 | 0.0% | 0.06% | +27.1% |
Q4 2016 | $2,159,000 | – | 256,400 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 831,440 | $7,674,000 | 13.79% |
Stonepine Capital Management, LLC | 1,852,395 | $17,098,000 | 9.23% |
Sarissa Capital Management LP | 1,025,000 | $9,460,000 | 3.16% |
Opaleye Management Inc. | 750,000 | $6,922,000 | 2.89% |
Broadfin Capital, LLC | 1,948,554 | $17,985,000 | 2.18% |
ARMISTICE CAPITAL, LLC | 1,852,000 | $17,094,000 | 2.18% |
JW Asset Management, LLC | 315,980 | $2,916,000 | 1.86% |
Tiger Legatus Capital Management, LLC | 450,000 | $4,154,000 | 1.69% |
KNOTT DAVID M | 109,184 | $1,008,000 | 0.42% |
Ancora Advisors LLC | 507,981 | $4,688,000 | 0.30% |